India recorded over 85,000 new COVID-19 cases in the last 24 hours taking the total past the 59 lakh-mark on Saturday. Over 1,000 deaths were also recorded in the past 24 hours, taking the fatality past 93,000. The number of recoveries in the last 24 hours stood at 93,000. With this, the total recoveries stand at 48 lakh.
Around 13.4 lakh COVID-19 tests were conducted during the same period. India ranks second, next only to the US, in number of active cases of COVID-19.
In all 85,362 new cases and 1,089 deaths were recorded in the last 24 hours. The total cases in the country are 59,03,932 including 9,60,969 active cases while the total death is 93,379.
Active COVID-19 cases in Maharashtra were at 2,73,190, Karnataka 98,493, Andhra Pradesh 67,683, Uttar Pradesh 59,397 and Tamil Nadu 46,386.
So far 7,02,69,975 samples have been tested.
COVID-19 vaccine trial begins in Mumbai on Saturday
The first dose of COVID-19 vaccine developed by the Oxford University and AstraZeneca will be administered to three volunteers at the King Edward Memorial (KEM) Hospital in Mumbai on Saturday.
10 more volunteers have been selected for the clinical trial. Clinical trials will also begin in BYL Nair hospital for the same vaccine on Monday.
Volunteers at the KEM hospital who will be administered the vaccine will be checked regularly and will get a second dose within 29 days.
All three volunteers have been screened for health issues and have also undergone RT-PCR and antibody testing. They have also been screened for comorbid conditions. One of them will be given a placebo and not the drug.
The volunteers have also been covered with Rs1 crore life insurance in case of death due to any side effects during the trial and are also covered under the Rs50 lakh medical insurance if they develop any adverse effect from the vaccine.
COVID-19 vaccine and situation around the world
The United States on Friday crossed seven million confirmed corona cases. India comes second with 5.8 million cases and Brazil third with 4.7 million.
Media reports said a single dose of Johnson & Johnson’s experimental corona vaccine produced a strong immune response against the disease in a mid-stage clinical trial. The results of the trial were published on Friday.
The WHO meanwhile warned that two million corona fatalities are very likely without relentless action to combat the disease.
To read the latest news in Gujarati click here